Programs
- Resistance Networks
- Focused Antibiotics
- VISIBLE
- FORM
- The Missed Vital Sign
- CARE
- Untangling Addiction
- Dynamic Resilience
- Q4Bio
- SAVE
- In Utero
- R3 Global
- MCPsych
- Delta Tissue
- 1kD
- HOPE
Women’s Health
Team
News
Stories

Home » News » Wellcome Leap Appoints John Young and Thomas Glanzmann to Board of Directors » Untitled-3

Untitled-3

© 2022 Wellcome Leap Inc. All Rights Reserved.

© 2022 Wellcome Leap Inc. All Rights Reserved.

© 2026 Wellcome Leap Inc. All Rights Reserved.

Wellcome Leap is a 501(c)(3) organization.